Fuminori Abe

This inventor holds 13 USPTO granted patents and 1 published patent application and 8 EPO patents. Top assignees: Sbi Pharmaceuticals Co., Ltd., National Center for Child Health and Development, Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. Active years: 1988-2018.

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 92.3

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 28(Granted Patents)

Company Filing History:

11 out of 41

Sbi Pharmaceuticals Co., Ltd.

patents

4 out of 15

National Center for Child Health and Development

patents

2 out of 212

Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai

The University of Tokyo

patents

6. 1 out of 1

Tokyo University Agriculture Educational Corporation

patent

where one patent can have more than one assignee

Years Active: 1988-2018

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10022345 - Agent for preventing and/or treating veisalgia (2018-07-17),

2. 9937138 - Enhancer of survival of transplanted organ (2018-04-10),

3. 9901558 - Enhancer of survival of transplanted organ (2018-02-27),

4. 9895331 - Prophylactic and/or therapeutic agent for radiation damage (2018-02-20),

5. 9539225 - Anemia of cancer improving/prophylactic agent (2017-01-10),

6. 9488664 - Diagnostic agent for tumor (2016-11-08),

7. 9475755 - Prophylactic agent for chronic kidney disease (2016-10-25),

8. 9474770 - Prophylactic agent and/or therapeutic agent for sepsis (2016-10-25),

9. 9399029 - Immune tolerance inducer (2016-07-26),

10. 9314443 - Enhancer of survival of transplanted organ (2016-04-19),

11. 9012502 - Cancer heat therapy-enhancing agent (2015-04-21),

12. 4851446 - Immunosuppressing method (1989-07-25),

13. 4778824 - Method for suppressing a transplantation immunity and treating an (1988-10-18),

Title: Fuminori Abe: Innovator in Medical Solutions

Introduction

Fuminori Abe is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, holding a total of 13 patents. His work focuses on developing innovative solutions for health-related challenges.

Latest Patents

Among his latest patents is an agent for preventing and/or treating veisalgia. The objective of this invention is to provide a hangover prophylactic and/or therapeutic agent comprising ALAs. Another notable patent is an enhancer of survival of transplanted organs. This invention promotes graft survival while suppressing rejection without the use of existing immunosuppressants. It includes an organ preservation solution capable of maintaining the freshness of an organ excised from a donor. The active ingredients in this solution comprise 5-aminolevulinic acid (ALA) or its derivatives, along with an iron compound such as sodium ferrous citrate.

Career Highlights

Fuminori Abe has worked with several reputable organizations throughout his career. He has been associated with Sbi Pharmaceuticals Co., Ltd. and the National Center for Child Health and Development. His work in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Fuminori has collaborated with notable colleagues, including Tohru Tanaka and Motowo Nakajima. Their joint efforts have further enhanced the impact of his inventions in the medical field.

Conclusion

Fuminori Abe's innovative contributions to medicine, particularly in organ preservation and hangover treatment, highlight his role as a leading inventor. His patents reflect a commitment to improving health outcomes through scientific advancements.